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Acid-base changes and acetate metabolism during routine and
high-efficiency hemodialysis in children. Changes in acid-base
status and plasma acetate concentrations were studied in eight
children during 11 hemodialysis sessions. During dialysis, the
blood bicarbonate concentration fell (20.5 0.7 to 19.6 0.8
mEq/liter), the Pco2 fell (33.4 0.8 to 27.5 1.4 mm Hg), and
the pH rose (7.42 0.01 to 7.48 0.02). During the hour after
dialysis, the bicarbonate concentration rose to normal (23.4
0.7 mEq/liter), the Pco2 rose (32.8 0.8 mm Hg), and the pH
remained unchanged. The half-life of plasma acetate, measured
alter dialysis, was 8.7 mm. During five "high-efficiency" dialysis
sessions (urea clearance, > 3.0 mllmin/kg), blood bicarbonate
concentration fell 3.2 mEq/liter, Pco2 fell 8.7 mm Hg, and plasma
acetate rose to 7.51 mmoles/liter, whereas during six "routine
efficiency" dialysis sessions (urea clearance, 1.5 to 3.0 mI/mini
kg), blood bicarbonate rose 1.0 mEq/liter, Pco2 fell 36 mm Hg,
and plasma acetate rose to 3.52 mmoles/liter. At 1 hour alter the
end of dialysis, blood bicarbonate, Pco2, and plasma acetate con-
centrations were similar in the two groups. Clinical problems oc-
curred more frequently in the high-efficiency group during dial-
ysis although the difference was not significant. The data indicate
that (1) dialysis with acetate buffer effectively corrects pre-
dialysis metabolic acidosis, (2) although children have a high rate
of acetate metabolism, during high-efficiency dialysis this rate is
exceeded by the influx of acetate, and acid-base abnormalities
occur. These abnormalities are transient but may cause clinical
problems.
Modifications acido-basiques et métabolisme de l'acétate au
cours de l'hémodialyse de routine ou a eflicacité élevée chez
l'enfant. Les modifications de l'état acido-basique et des concen-
trations plasmatiques d'acétate ont été étudiées chez huit en-
fants au cours de 11 seances d'hCmodialyse. Au cours de Ia dial-
yse les bicarbonates diminuent (20,5 0,7 a 19,6 0,8 mEqI
litre), Ia Pco2 diminue (33,4 0,8 a 27,5 1,4mm Hg), et le pH
augmente (7,42 0,01 a 7,48 0,02). Au cours de l'heure qui
suit Ia dialyse les bicarbonates s'élèvent a une valeur normale,
23,4 0,07 mEq/litre, Ia Pco2 s'élêve a 32,8 0,8 mm Hg, et le
pH est inchangé. La demi vie de l'acCtate plasmatique, mesurée
après Ia dialyse, Ctait de 8,7 mm. Au cours de cinq sCances de
dialyse a haute efficacitd (clearance de l'urée, > 3,0 mllminlkg)
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les bicarbonates baissent de 3,2 mEq/litre, Ia Pco2 de 8,7 mm
Hg, et l'acétate plasmatique s'est élevé a 7,51 mmoles/litre alors
qu'au cours de six seances de dialyse d'efficacitC moyenne
(clearance de l'urCe, 1,5 a 3,0 mI/mm/kg) les bicarbonates ont
augmenté de 1,0 mEq/litre, Ia Pco2 a diminué de 3,6 mm Hg, et
l'acétate plasmatique s'est élevé a 3,52 mmoles/litre. Une heure
aprês la fin de la dialyse les bicarbonates, la Pco2 et l'acCtate
plasmatique étaient semblables dans les deux groupes. Des pro-
blémes cliniques sont survenus plus souvent au cours de la dial-
yse dans le groups a haute efficacité bien que Ia difference ne soit
pas significative. Ces rCsultats indiquent que (1) Ia dialyse avec le
tampon acetate corrige efficacement l'acidose métabolique pre-
dialytique, (2) bien que l'enfant ait une capacitC élevCe de méta-
boliser l'acétate, cette capacite est débordée, au cours de Ia dial-
yse a haute efficacité, par l'entrée d'acétate et des anomalies
acidobasiques surviennent. Ces anomalies sont transitoires et
peuvent determiner des problemes cliniques.
End-stage renal disease leads to many metabolic
disorders, one being chronic metabolic acidosis.
Hemodialysis treatment corrects this acidosis by
supplying the patient with a buffer source. The most
frequently used buffer is sodium acetate. During
hemodialysis, the patient receives acetate that must
be metabolized in order to generate bicarbonate.
At the same time, however, bicarbonate is re-
moved by the dialysis process. If the rate of ace-
tate infusion is greater than the patient's ability
to metabolize it, acetate will be accumulated by the
patient. Similarly, if the rate of bicarbonate removal
exceeds the rate at which bicarbonate is generated
from acetate, metabolic acidosis will worsen during
dialysis. Therefore, the effectiveness of the acid-
base correction by hemodialysis depends on the bal-
ance between the efficiency of dialysis (rate of
transfer of acetate and bicarbonate) and the pa-
tient's ability to metabolize acetate.
Acid-base homeostasis and acetate metabolism
during dialysis have been studied in adults, but
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there is little information available on children. Two
earlier studies [1, 2] suggested that some hemo-
dialysis patients metabolized acetate slowly; they
were defined as "acetate intolerant." These pa-
tients were identified by the development of high
concentrations of plasma acetate and worsening
acidosis during dialysis. A later study [3] estab-
lished that high-efficiency dialysis (the use of large
surface area artificial kidneys and high blood flow
rates) in adults caused worsening acidosis and other
adverse metabolic effects during dialysis. A recent
study [4] reported that the use of bicarbonate in-
stead of acetate in the dialysate resulted in better
patient tolerance of hemodialysis. At present, the
relative importance of the efficiency of dialysis and
of the patient's metabolic capacity in determining
acetate and acid-base metabolism is unclear. In ad-
dition, the metabolic capacity of children for ace-
tate has not been defined.
Our study was designed to define the acid-base
and acetate changes during acetate-based hemo-
dialysis and the effectiveness of hemodialysis in
correcting metabolic acidosis in children. In addi-
tion, the effect of high-efficiency hemodialysis on
acid-base homeostasis during dialysis was eval-
uated.
Methods
Patients. Acid-base homeostasis and acetate me-
tabolism were investigated during 11 hemodialysis
sessions for five girls and three boys, 6 to 17 years
of age, at The Children's Renal Center of the Uni-
versity of California at San Francisco after in-
formed consent was obtained. Individual patient
data are listed in Table 1. Three children (patients I,
7, and 8) were studied twice, once during their first
week of hemodialysis and again after at least 6
weeks of intermittent hemodialysis. All other pa-
tients had been undergoing chronic hemodialysis
for at least 6 months, except for patient 5 who was
studied only during her first week of dialysis. None
of the children had diabetes mellitus, hepatic in-
sufficiency, or heart failure.
Hemodialysis procedures. Using Drake-Willock
volume-proportioning dialysis units (#40 15) and
Cobe dialysate without glucose, we prepared and
primed the artificial kidneys (Cordis Dow 1.3 Hol-
low Fiber, Gambro Optima 13.5 and 17, and Gam-
bro Minor) in the usual manner. The size and type
of artificial kidney, the rate of blood flow, the rate of
ultrafiltration, and the heparinization procedures
were chosen by the staff of the dialysis unit based
on the needs of each patient. Therefore, only the
method of beginning and ending dialysis and the
collection of blood and dialysate samples were
modified to fit the experimental procedure.
In children with arteriovenous shunts, the shunts
were opened, heparin was injected, and the arterial
and venous sides of the shunt were clamped. In
children with arteriovenous fistulas, the arterial
needle was placed against the direction of blood
flow, and the venous needle was placed in the direc-
tion of blood flow, the two needles separated as
much as possible to minimize the degree of arterial-
venous mixing. Before connecting the child to the
blood lines of the dialysis system, we pumped 800
ml of 0.9% saline through the blood side of the sys-
tem to remove any acetate that had diffused from
the dialysate to the blood side of the system. Then
we connected the child to the blood lines but left
arterial and venous lines clamped. After setting the
blood pump to the correct flow rate, we abruptly
began hemodialysis by unclamping the arterial
blood line, turning on the dialysis machine and
blood pump, and unclamping the venous line in rap-
id succession (t = 0, where t is time). During the 4
hours of dialysis, we collected all outfiowing dialy-
sate in a sealed vat for measurement of dialysate
volume. After 4 hours of hemodialysis, we abruptly
ended dialysis by clamping the venous line, turning
off the machine and blood pump, and clamping the
arterial line (t = 240 mm). The abrupt beginning and
ending of the hemodialysis session allowed for more
accurate measurement of both the gain and loss of
substances during dialysis and the changes of
plasma acetate during and after hemodialysis. After
the end of hemodialysis, the blood remaining in the
blood lines and artificial kidney was recirculated for
1 hour, while the disappearance curve of acetate
from the body was measured. Finally, we reinfused
the recirculating blood.
Collection and analysis of samples: (1) Collec-
tion. Blood for measurement of plasma acetate con-
centration was collected immediately before hemo-
dialysis (t = 0), at 5, 10, 15, 30, 60, 120, 180, and 240
mm after hemodialysis began and at 2, 5, 10, 15, 30,
and 60 mm after hemodialysis ended. Blood for
measurement of pH, Pco2, and bicarbonate was col-
lected before dialysis, at 30, 60, 120, 180, and 240
mm after dialysis began, and at 60 mm after dialysis
ended. Blood for measurement of the concentra-
tions of plasma organic acids was collected prior to
dialysis, at the end of dialysis (240 mm), and 60 mm
after dialysis. Dialysate samples, both inflowing
(Di) and outfiowing (D0) were collected for determi-
nation of acetate, Pco2, and total carbon dioxide
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content and bicarbonate at 30, 60, 120, 180, and 240
mm after the start of dialysis.
(2) Plasma and dialvsate acetate. Blood samples
were collected from the arterial blood line in hepa-
rinized syringes and were immediately injected into
heparinized tubes and centrifuged to separate the
plasma from the red blood cells. The plasma was
placed in stoppered test tubes and kept on ice until
the experiment was completed and was then frozen
at —20° C until the time of analysis. After depro-
teinization and vacuum microdistillation of the
plasma, plasma acetate was measured by gas chro-
matography as previously described [5]. Dialysate
samples were not deproteinized or vacuum distilled
but were diluted with water (1:40) and measured di-
rectly by gas chromatography.
(3) Blood pH, Pco2, and bicarbonate and dialy-
sate Pco2. Blood and dialysate samples were col-
lected in heparinized syringes, kept in ice, and ana-
lyzed within 30 mm. Blood pH, pCO2, bicarbonate,
and dialysate Pco2 were measured on a blood-gas
analyzer (Corning).
(4) Dialysate total carbon dioxide content and bi-
carbonate. Dialysate samples were collected in sy-
ringes, injected into rubber stoppered tubes, and kept
frozen until analysis. Total carbon dioxide was de-
termined with a total carbon analyzer (Oceanogra-
phy International, College Station, Texas) as follows.
The sample was injected into a chamber of the ana-
lyzer that contains 5 N phosphoric acid and con-
verts all bicarbonate to carbon dioxide. The solu-
tion was continually flushed with carbon-dioxide-
free nitrogen, and all carbon dioxide was carried
past the infrared detector, which measures a peak
of carbon dioxide absorption. The area under the
peak was measured by an integrator with a digital
readout. The measurement of the sample was com-
pared with measurements of standard sodium car-
bonate solutions to calculate total carbon dioxide.
Dialysate bicarbonate was calculated from the mea-
sured Pco2 (Corning blood gas analyzer) and total
carbon dioxide as follows:
[HCO3-] = [total C02] — [0.03 x Pco2]
(5) Organic acids. Lactate, pyruvate, citrate, /3-
hydroxybutyrate, and acetoacetate were measured
in the frozen plasma samples collected in the same
manner as the acetate plasma samples. The plasma
was deproteinized with perchloric acid, and the
concentrations of the organic acids were deter-
mined with NAD-linked enzymatic assays accord-
ing to procedures described by Bergmeyer [6].
Abbreviations and formulas. The following ab-
breviations are used:
= flow rate (mi/mm)
= concentration (mEq/iiter or mM)
= incoming dialysate
= outgoing dialysate
= incoming (arterial) blood
= ultrafiltration flow rate (mI/mm)
= ultrafiltration constant
= transmembrane pressure (mm Hg)
= flux rate, (i.e. transfer rate of a solute to or
from the dialysate)
= dialysance (mi/mm)
= clearance (mi/mm)
= bicarbonate
= acetate
= organic acids
= half life (mm)
The following formulas [7] are used:
N = QD0 X CD0 — QD! X CDI
D N— c —
CBI
Calculation of acid-base mass balance during he-
modialysis. Total base equivalents received dur-
ing dialysis equals the acetate infused minus the
loss of bicarbonate and organic acids; that is, total
base = Ac gain — Bic loss — Oa loss.
Acetate infused during dialysis was determined
by measuring the rate of transfer or flux (N) of ace-
tate at 0.5, 1, 2, 3, and 4 hours during dialysis, and
multiplying by the number of minutes in the period
that the measurement represented (for example, N
at 1 hour x 30 mm = acetate infused between 0.5
and 1 hour). The total acetate gain for one dialysis
session was the sum of the acetate infused during all
the periods. The rate of transfer of acetate was de-
termined from the rate of loss from the dialysate as
follows:
NAC = QDI X CDI(Ac) — QDO X CDO(AC)
Quo was determined by dividing the weight of the
dialysate collected over a timed period by the num-
ber of minutes in that period. cDIAC and cDO(AC) were
measured as described in the analysis of the plasma
samples. QDI was calculated as follows:
QDI = QD0 — Q
Q, = U, x TMP
Q
c
D1
D0
B,
Qf
Uk
TMP
N
D
C
Bic
Ac
Oa
t 1/2
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TMP was calculated from the pressure gauges of the
dialysis machine. Uk is different for each artificial
kidney. The Uk values (mi/hr/mm Hg) are 1.8 for
the C-DAK-1.3, 1.32 for the Gambro minor, 2.5 for
the Gambro Optima- 17, and 4.4 for the Gambro Op-
tima-13 .5. Therefore,
NAC = (QDO — Q) X cD!(AC) — Qi X cDO(AC)
The total bicarbonate lost during dialysis was de-
termined by measuring the rate of transfer of bi-
carbonate in the same manner as described for ace-
tate. The transfer of bicarbonate is determined from
the gain of bicarbonate by the dialysate according to
the following formula:
= Q >< — (QDO — Q) x CDI(B1c)
The total organic acid lost during dialysis was es-
timated from the end-dialysis plasma concentration
of each organic acid and the previous published val-
ues for the dialysance of each organic acid (for ex-
ample, total lactate lost = Ciactate (mmoles/ml) x
Diactate (mi/mm) x 240 mm). The amount lost for
each organic acid was summed to give an estimate
of total organic acid lost. All organic acid concen-
trations represent equimolar concentrations of po-
tential bicarbonate except citrate, which is a tn-
carboxylic acid and can yield 3 moles of bicarbo-
nate per mole of citrate.
Estimate of the patient's rate of acetate metabo-
lism by plasma half-life (t'/2). Using the MLAB
computer program developed at the National In-
stitute of Health, we fitted the decreasing concen-
trations of plasma acetate after hemodialysis ended
to a monoexponential disappearance curve and cal-
culated the half-life, which was taken as an estimate
of the patient's rate of acetate metabolism.
Correlations. The changes resulting from hemo-
dialysis (blood bicarbonate concentration, plasma
acetate concentration, and base transfer) were cor-
related with the two factors controlling the acid-
base changes during dialysis: efficiency of dialysis
and the patient's rate of acetate metabolism (tV2).
To estimate the efficiency of dialysis, we divided
the clearance of urea and the dialysance of acetate
by the weight of the patient. The urea clearance was
calculated from published data [8—10] for the arti-
ficial kidney used and the patient's blood flow. The
dialysance of acetate was measured by the formula
previously given.
High efficiency hemodialysis. In children, ef-
fective hemodialysis is defined by a urea clear-
ance (Curea) of 2 to 3 mllmin/kg of body wt
[11]. Dialysis sessions were divided into a high-effi-
ciency group, Curea > 3 mllmin/kg, and a routine-
efficiency group, Curea  3 ml/min/kg. There were
five studies in the high-efficiency group and six in
the routine group. Two patients (1 and 8) were stud-
ied in both groups. The two groups were compared
for changes in acid-base status, plasma acetate, bal-
ance of base transfer, and clinical problems. The
clinical problems evaluated were the episodes of
hypotension requiring saline infusion and the epi-
sodes of nausea and vomiting recorded by the staff
during dialysis.
Statistical analysis. The high- and routine-effi-
ciency groups were compared by Student's t test
and the Mann-Whitney test, when indicated. Cone-
lations were performed by linear regression analysis
by the method of least squares.
Results
Effects of hemodialysis on blood pH, Pco2, and
bicarbonate and on plasma acetate (Table 1, Fig.
1). During hemodialysis, the blood pH rose from a
predialysis value of 7.42 0.01 to an end-dialysis
value of 7.48 0.02 (P < 0.002). This rise of pH
was due to a decrease in Pco2 from 33.4 0.8 to
27.5 1.4 mm Hg (P < 0.001) during dialysis. The
blood bicarbonate concentration also decreased
slightly but not significantly from 20.5 0.7 mEq/
liter before dialysis to 19.5 0.8 mEq/liter (P =
NS) after the first hour of hemodialysis and then re-
mained unchanged. The plasma acetate concentra-
tion increased rapidly during the first hour from a
predialysis concentration of 0.06 0.01 to 3.24
0.33 mi (P < 0.001) and then slowly rose to 5.32
0.82 (P < 0.001) at the end of dialysis. When hemo-
dialysis ended, the remaining acetate was rapidly
metabolized, the concentration falling to 0.13
0.03 mt (P < 0.001) at 1 hour after dialysis. During
the 1-hour period after dialysis, the bicarbonate
concentration rebounded from its end dialysis con-
centration to 23.4 0.7 mEq/liter (P < 0.001) be-
cause the remaining acetate was metabolized. Dur-
ing this period, the Pco2 increased from its end-dial-
ysis concentration to 32.8 0.8 mm Hg (P < 0.001),
and the pH remained unchanged (7.48 0.02) be-
cause of the parallel increase of the Pco2 and the
bicarbonate.
Effect of hemodialysis on plasma organic acids
other than acetate (Table 2). f3-Hydroxybutyrate in-
creased significantly during dialysis and remained
unchanged at 1 hour after dialysis. Lactate de-
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Table 1. Pediatric hemodialysis descriptive patient and dialysis information, acetate and bicarbonate changes during hemodialysis, and
balance of base equivalents resulting from hemodialysis
Patients
Age
Yr
Weight
kg
Acetate
t'/2
mm
Type of
kidney°
Curea
mi/kg/mm
DAC
mI/kg/mm
Blood bicarbonate, mEq/liter
Qi' Before
mi/kg/hr dialysis
End
of dialysis
1 Hr
after
dialysis
la
lb
2
3
4
5
6
7a
7b
8a
8b
10 7/12
111/12
10 10/12
15 6/12
17 5/12
1111/12
13 2/12
13 1/12
13 3/12
66/12
69/12
32.2
33.5
27.2
60.0
73.8
25.4
40.9
35.9
37.7
19.4
20.2
11.0
11.9
6.6
5.3
9.4
9.2
12.8
10.7
9.2
5.10
4.0
G. Minor
C-DAK 1.3
G. Minor
G. 13.5
G. 17.0
G. Minor
C-DAK 1.3
C-DAK 1.3
C-DAK 1.3
G. Minor
G. Minor
2.17
3.28
2.76
2.37
1.49
2.95
3.50
3.48
3.05
3.10
2.97
1.63
2.60
2.43
1.52
1.20
2.29
2.65
2.88
2.21
3.39
2.45
1.4 18.4
4.0 22.6
1.5 17.7
8.4 22.3
2.5 20.9
13.5 16.1
5.2 20.8
2.0 20.6
3.9 22.8
8.9 21.7
10.1 21.1
21.1
16.7
19.0
21.5
18.8
17.7
18.9
15.8
19.4
21.9
24.3
22.8
22.4
19.4
24.0
20.6
23.2
23.4
23.8
27.5
24.9
25.8
Mean
SEM
11 9/12 36.9 8.7 2.83 2.30 5.6 20.5 19.6 23.4
a Artificial kidney, type and size (surface area): C-DAK 1.3, Cordis Dow Hollow Fiber (1.3 m2); G. Minor, Gambro Lundia Minor,
Parallel Plate (0.54 m2); G-13.5, Gambro Lundia Optima 13.5, Parallel Plate (1.0 m2); G-17.0, Gambro Lundia Optima 17.0, Parallel Plate
(1.02)
b DAC is acetate dialysance; QF is ultrafiltration flow rate.
creased significantly during dialysis but returned to-
ward its predialysis concentration at 1 hour after
dialysis. Citrate did not change significantly from
predialysis to 1 hour after dialysis. The concentra-
tions of pyruvate and acetoacetate both fell signifi-
cantly during dialysis, but their concentrations were
so low, they had little effect on the overall organic
acid change. The sum of the concentrations of all
five organic acids increased from 2.1 m before
dialysis to 2.8 mt at the end of dialysis and to 3.1
m at 1 hour after dialysis.
Balance of base equivalents during hemodialysis
(Table 1). During hemodialysis, the children re-
ceived 19.2 1.4 mmoles/kg body wt acetate and
lost 12.7 0.1 mmoles/kg of body wt bicarbonate.
In addition to the loss of bicarbqnate, the children
also lost organic acids, which, like acetate, are po-
tential base equivalents. The com6ined losses of the
organic acids were estimated to be 1.7 0.2
mmoles/kg/dialysis. Therefore, the amount of po-
tential base gain per dialysis was 4.9 0.9 mmoles/
kg. Because the patients were dialyzed three times
per week, they received 14.7 mmoles/kg/week of
potential base, or 2.1 mmoles/day.
Plasma acetate half-life. The disappearance of
plasma acetate after the end of hemodialysis was
fitted to a monoexponential decay curve. As deter-
Fig. 1. Acid-base and acetate changes during 11 hemodialysis mined by this method, the mean t'/2 of acetate in
procedures in children. Data are the means SEM. the plasma was 8.7 0.4 mm.
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Table 1. (continued)
Plasma acetate, m
Balance of base equivalents, mmoles
1 Hr
Before End after Acetate HCO3 Organic acid Potential
dialysis of dialysis dialysis gain lost lost base gain
0.09 1.95 0.06 511 352 28 131
0.03 8.81 0.25 662 482 84 %
0.07 4.97 0.14 556 307 63 186
0.06 2.29 0,05 797 651 48 98
0.04 3.24 0.07 815 475 84 256
0.11 6.41 0.10 513 266 45 202
0.05 7.75 0.32 864 651 54 159
0.09 8.83 0.02 797 480 108 204
0.06 7.92 0.16 651 557 56 38
0.07 4.18 0.07 520 275 27 219
0.02 2.18 0.02 455 332 32 91
0.06 5.32 0.13 649 349 57 153
±0.01 ±0.82 ±0.03 ±44 ±43 ±8 ±20
Table 2. Effect of hemodialysis on plasma organic acids other than acetate a
Predialysis End-dia1ysis' 1 Hr after dialySjS'
Lactate, m 1.38 ± 0.29 0.86 ± 0.14c 1.22 ± 0.26
f3-Hydroxybutyrate, mi 0.43 ± 0.09 1.70 ± 028d 1.61 ± 0.37
Citrate, m 0.15 ± 0.10 0.16 ± 0.01 0.16 ± 0.01
Pyruvate, m 0.08 ± 0.01 0.05 ± 0.01" 0.06 ± 0.01
Acetoacetate, mi 0.04 ± 0.01 0.01 ± 0.00" 0.01 ± 0.00
a Data are the means ± SEM of 11 dialysis procedures.
b There were no significant differences between end-dialysis and 1-hr postdialysis concentrations.
Significantly different from predialysis concentrations, P <0.05.
"Significantly different from predialysis concentrations, P <0.01.
Table 3. Correlation coefficients (r) between the efficiency of dialysis, the metabolic ability to metabolize acetate, and the acid-base
changes resulting from hemodialysisa
Curea
(mllmin/kg body wt)
Acetate dialysance
(ml/mii,Jk body wt)
Plasma acetate t'/2
(mm)
Acetate gain during dialysis
(mmoles/kgbodywt) 0.787" 0965" —0.166
Bicarbonate loss wiring dialysis
(mmoles/kgbocly wt) 0.843" 0.717c —0.024
Potential base gain
from dialysis
(mmoles/kg body wt) 0.221 0617d —0.286
End-dialysis plasma acetate
concentration (mM) 0.717 0.509 0632d
Change in blood
bicarbonate during dialysis
(mEq/liter) —0.317 —0.155 —0.545
Change in blood
bicarbonate after dialysis
(mEqlliter) 0594d 0.344 o.5o8
a Data are from 11 hemodialysis procedures.
b Significant correlation between variables, P <0.005.
Significant correlation between variables, P <0.01.
Ci Significant correlation between variables, P <0.05.
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Fig. 2. Acid-base and acetate changes in children undergoing
either routine efficiency (N = 6) or high efficiency (N = 5) hemo-
dialysis. Data are the means SEM. Symbols denoting statistical
significance between the concentrations of the routine and high
efficiency groups are *j) < 0.001, **P < 0.05.
Correlations (Table 3). By correlating both the ef-
ficiency of dialysis (measured by urea clearance and
dialysance of acetate factored for body weight) and
the child's ability to metabolize acetate (measured
by plasma half-life) to the change in plasma acetate,
the change in blood bicarbonate, and the potential
base gain, we attempted to evaluate the relative im-
portance of dialysis efficiency and metabolic capac-
ity for determining acid-base homeostasis resulting
from dialysis. Both measures of dialysis efficiency
had a significant positive correlation with acetate
gain and bicarbonate loss, but only DAC had a signif-
icant correlation to potential base gain. Plasma half-
life showed no correlation with acetate gain, base
loss, or potential base gain. Both urea clearance and
plasma half-life had a significant correlation to end-
dialysis acetate concentration. Neither the mea-
sures of dialysis efficiency nor the plasma half-life
correlated with the change in bicarbonate during
dialysis.
Effect of high-efficiency hemodialysis (Fig. 2,
Table 4). The ages, weights, predialysis acid-base
status, and plasma half-life of acetate were similar
in the children treated with high-efficiency dialysis
(Curea> 3 mL'minlkg) and routine-efficiency dialysis
(Curea  3 ml/min/kg). In addition, there was no sig-
nificant difference in the rate of ultrafiltration be-
tween the groups. Because of the manner in which
the groups were defined, the clearance of urea per
kilogram and the dialysance of acetate per kilogram
were significantly greater in the high-efficiency
group.
The changes in blood gases during dialysis were
markedly different between the two groups (Fig. 2,
Table 4). The bicarbonate concentration fell by 3.2
1.1 mEq/liter in the high-efficiency group and
rose by 1.0 0.8 mEq/liter in the routine-efficiency
group (P < 0.05). Although the Pco2 fell by 8.7
2.0 mm Hg in the high-efficiency group, it fell only
by 3.6 0.8 mm Hg in the routine-efficiency group
(P < 0.05). The result of these changes was an al-
most identical rise in pH in the two groups.
In the hour after dialysis, the increase in both bi-
carbonate concentration and Pco2 was significant-
ly greater in the high-efficiency group, 5.9 1.0
mEq/liter and 8.0 1.4 mm Hg, respectively, than
in the routine-efficiency group, 2.2 0.7 mEq and
3.1 1.1 mm Hg, respectively (P < 0.05 for both).
The pH remained unchanged in both groups.
The plasma acetate concentrations were signifi-
cantly greater in the high-efficiency group through-
out the entire procedure (Fig. 2). The plasma ace-
tate of the high-efficiency group rose rapidly in the
first hour of dialysis and continued to rise through
the entire dialysis session. In the routine-efficiency
group, plasma acetate rose rapidly in the first hour
of dialysis but then reached a steady state. At the
I
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end of dialysis, the high-efficiency group had an
acetate concentration twice that of the routine-effi-
ciency group (7.51 0.86 vs. 3.52 0.55 mM, P <
0.001). Plasma acetate fell rapidly after completion
of dialysis in both groups, but the high-efficiency
group maintained significantly higher acetate con-
centrations up to and including 1 hour after dialysis.
The balance of base equivalents was similar in the
two groups. Patients in the high-efficiency group
gained more acetate than did patients in the routine-
efficiency group (21.5 1.6 vs. 17.2 1.8 mmoles/
kg, P = NS), but the high-efficiency group lost more
bicarbonate (14.5 0.5 vs. 11.1 1.3 mmoles/kg, P
< 0.05). Therefore, both groups received similar
amounts of potential base.
Table 4 indicates the incidence of several clinical
problems during hemodialysis treatments. Although
the occurrence of hypotension, nausea, and vomit-
ing was more frequent during high-efficiency dial-
ysis than it was during routine-efficiency dialysis,
the difference was not statistically significant.
Discussion
The aim of the present study was to evaluate ace-
tate metabolism and acid-base homeostasis of chil-
dren undergoing conventional hemodialysis. In our
study, we evaluated eight children during 11 dif-
ferent dialysis sessions, with dialysate containing 38
m acetate. During dialysis, blood bicarbonate de-
creased slightly (20.0 to 19.5 mEq/liter), the Pco2
decreased (33.4 to 27.5 mm Hg), and the pH in-
creased (7.42 to 7.48). Plasma acetate slowly in-
creased during dialysis (0.06 to 5.3 mM). Although
during hemodialysis there was a slight fall in blood
bicarbonate, after the end of dialysis the acetate
that had accumulated was rapidly metabolized, and
bicarbonate rebounded above predialysis concen-
trations and towards normal. The blood Pco2 also
increased, and the parallel increase of Pco2 and bi-
carbonate maintained the pH in an alkaline range.
Hemodialysis with acetate as a buffer thus corrects
the base deficit of patients with renal failure, but
does so only after the treatment has ended.
The acetate and acid-base changes in children
were similar in character to the changes described
in adult patients receiving 40 mri acetate dialysate
and using large surface area dialyzers (2.5 m2) [3].
There were, however, two important differences
between the adults and the children. The adults
ended dialysis with a plasma acetate concentration
of 10 mM, almost double that of the children, and
the fall in blood bicarbonate during dialysis was 4
mEq/liter in the adults and only 0.5 mEq/liter in the
children. These differences could be explained ei-
ther by a more efficient dialysis in the adult patients,
or by a greater capacity to metabolize acetate by the
children. Because the efficiency of dialysis, as mea-
sured by the mass transfer rate of acetate, was
greater in children (4.8 mmoles/kglhour) than it was
in adults (3.6 mmoles/kglhour [3]), we would con-
clude that children have a greater capacity to me-
tabolize acetate, when corrected for body weight,
than do adults. This is probably due to the fact that
the metabolically active internal organs comprise a
larger percentage of body weight in children [12].
One important goal of dialysis is to supply enough
base to the patient to correct the acidosis of renal
failure. The base gain of the patient equals the ace-
tate gained minus the loss of bicarbonate and organ-
ic acids. The organic acids are important because,
like acetate, they consume a hydrogen ion when
metabolized, thus functioning as potential base. If
the loss of organic acids is not considered, the base
balance will be overestimated by 25 to 30%. Some
of this loss is occasioned by a 50% increase in
plasma concentration of organic acids during and
after dialysis, similar to the findings of Toichin et al
[3]. The increase may be due to the load of acetate
the patient receives that must be metabolized
through conversion to acetyl-CoA. When large
quantities of acetyl-C0A are formed, some may be
diverted to organic acids; in addition, the con-
version of pyruvate, formed from glucose, to ace-
tyl-C0A may be inhibited, resulting in the formation
of lactate and other organic acids. The fact that our
dialysate contained no glucose may also contribute
to the increase of organic acids, because glucose
lost to the dialysate may produce a type of star-
vation ketosis. The exact mechanism of this in-
crease in organic acids remains unresolved.
The balance of base equivalents during hemo-
dialysis indicates that the children received a poten-
tial base of 2.1 mEq/kglday. Because the estimated
acid production (without a known source of base
loss) is between 1 and 3 mEq/kg/day [13, 14], hemo-
dialysis with sodium acetate should supply the
needed base. Prior to dialysis, however, the chil-
dren had a compensated metabolic acidosis (PH,
7.42; Pco2, 33.4 mm Hg; and bicarbonate, 20.3
mEq/liter), a finding also observed in adults [15].
The reasons for this acidosis in the presence of
what seems to be adequate base delivery during he-
modialysis is unclear. There are several possible ex-
planations: (1) Some of the children may have lost
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Table 4. Comparison of the effects of high efficiency and routine efficiency hemodialysis'
Patient information before dialysis
Dialysis efficiency
Age
yrs
Weight
kg pH
Pco2
mm Hg
HCO3-
mM
Acetate 0/2
mm Cre
—_______________________________
DAC QF
mi/mm/kg mI/mm/kg mi/hr/kg
High (N = 5) 11.4 33.5 7.43 33.8 21.7 10.0 3.28 2.75 4.8
Routine (N = 6) 12.0 39.8 7.40 33.1 19.4 7.6 2•45d l.92c 6.2
a Values represent the means SEM. Qr is ultrafiltration flow rate; DA is acetate dialysance.
b indicates change occurring during hemodialysis. Rebound indicates change occurring in the hour after dialysis.
High efficiency significantly greater than routine efficiency, P < 0.05.
d High efficiency significantly greater than routine efficiency, P < 0.01.
bicarbonate in their urine (although this was not
evaluated in our patients, only 3 of 8 had significant
urine output). (2) Some children were studied dur-
ing their initial month of dialysis when there may be
a greater need to replenish bone buffer. (3) Children
on hemodialysis may have a greater base need than
has been estimated in the past. For a fuller defini-
tion of acid-base balance of children undergoing he-
modialysis, a more exact and long-term base bal-
ance study is needed, where urine and stool base
loss, dietary acid intake, and changes in bone con-
tent are also evaluated.
Although our results suggest that, in general, ace-
tate is an adequate buffer for children undergoing
hemodialysis, they also suggest that with higher ef-
ficiency dialysis the children have greater acid-base
and acetate changes during and after dialysis, which
may be undesireable. The two factors that control
acid-base and acetate changes during dialysis are
the patient's ability to metabolize acetate and the
efficiency of dialysis. When we compared high effi-
ciency and routine efficiency dialysis, children in
the high-efficiency group had a greater decrease in
Pco2 during dialysis, which can probably be ex-
plained by increased removal of total carbon diox-
ide during dialysis [16] or possibly by a respiratory
change [17]. They also had a decrease in blood bi-
carbonate and a large increase in plasma acetate
throughout the 4 hours of dialysis, whereas the chil-
dren in the routine efficiency group had an increase
in bicarbonate and a moderate increase in acetate,
most of which occurred during the first hour of dial-
ysis. Thus, children in the high-efficiency group re-
ceived acetate and lost bicarbonate at a rate ex-
ceeding their metabolic ability to generate bicarbo-
nate from acetate. Therefore, even though children
have a greater ability (per kilogram of body weight)
to metabolize acetate than adults, hemodialysis
may still be too efficient, which results in worsening
of metabolic acidosis and the accumulation of ace-
tate during dialysis.
The metabolic consequences of high-efficiency
dialysis may have accounted for the slightly greater
occurrence of hypotensive episodes, nausea, and
vomiting in the children of this group. The problems
associated with high-efficiency dialysis when ace-
tate dialysate is used have been investigated in
adults [4]. In this study, patients undergoing hemo-
dialysis with large-surface-area dialyzers were com-
pared by the use of either acetate dialysate or bi-
carbonate dialysate, which would eliminate the de-
crease in bicarbonate and the accumulation of
acetate described with acetate dialysate. The same
patients, undergoing dialysis with similar efficiency
conditions, had a significantly lower incidence of
nausea, vomiting, headache, fatigue, and hypoten-
sion after bicarbonate replaced acetate in the dialy-
sate. In other studies, high levels of acetate have
been associated with cardiovascular instability [18,
19], and rapid changes in bicarbonate have been as-
sociated with central nervous system disequilibrium
[20, 21]. Although the clinical problems associated
with hemodialysis stem from many causes, certain
metabolic problems can clearly be attributed to
high-efficiency hemodialysis when an acetate dialy-
sate is used. Therefore, we would suggest that dial-
ysis with a urea clearance of greater than 3 mllmin/
kg may be harmful in children and should be avoid-
ed.
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Table 4. (continued)
Acid-base and acetate changes
during and after dialysis" Balance of base equivalents Clinical problems
no. of episodes!
dialysis session
pH
Rebound
pH
Rebound
Pco2 Pco2 HCO3
mm Hg mm Hg mM
Rebound
HCO3
mM
End
acetate
mM
Acetate HCO3- Potential
gain lost base
mmoles!kg mmoles/kg mmoles/kg Hypotension Vomiting Nausea
0.06 0.00 —8.7 8.0 5.9 7.50 21.5 14.5 5.0 0.4 1.6
1.0
±0.8
2.2c 351d 17.2 ll.le 4.8 1.0 0.0 07
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